The DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index.
Treg and CTLA-4: Two intertwining pathways to immune tolerance
Open accessAbstract
Both the CTLA-4 pathway and regulatory T cells (Treg) are essential for the control of immune homeostasis. Their therapeutic relevance is highlighted by the increasing use of anti-CTLA-4 antibody in tumor therapy and the development of Treg cell transfer strategies for use in autoimmunity and transplantation settings. The CTLA-4 pathway first came to the attention of the immunological community in 1995 with the discovery that mice deficient in Ctla-4 suffered a fatal lymphoproliferative syndrome. Eight years later, mice lacking the critical Treg transcription factor Foxp3 were shown to exhibit a remarkably similar phenotype. Much of the debate since has centered on the question of whether Treg suppressive function requires CTLA-4. The finding that it does in some settings but not in others has provoked controversy and inevitable polarization of opinion. In this article, I suggest that CTLA-4 and Treg represent complementary and largely overlapping mechanisms of immune tolerance. I argue that Treg commonly use CTLA-4 to effect suppression, however CTLA-4 can also function in the non-Treg compartment while Treg can invoke CTLA-4-independent mechanisms of suppression. The notion that Foxp3 and CTLA-4 direct independent programs of immune regulation, which in practice overlap to a significant extent, will hopefully help move us towards a better appreciation of the underlying biology and therapeutic significance of these pathways.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
Zhang, L., Xu, J., Zhang, X., Zhang, Y., Wang, L., Huang, X., & Xu, Z. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479442 · Cited by 4,088
Vignali, D. A. A., Collison, L. W., & Workman, C. J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2343 · Cited by 3,463
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,402
CTLA-4 Control over Foxp3 + Regulatory T Cell Function
Wing, K., Onishi, Y., Prieto-Martin, P., Yamaguchi, T., Miyara, M., Fehervari, Z., Nomura, T., & Sakaguchi, S. (2008) · Science · doi:10.1126/science.1160062 · Cited by 2,956
Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,856
Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4
Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H., & Mak, T. W. (1995) · Science · doi:10.1126/science.270.5238.985 · Cited by 2,766 · cited 2×
“found to exhibit dysregulated T cell immunity resulting in tissue infiltration and death around 3wk of age [3,4].”
BackgroundCD28/B7 SYSTEM OF T CELL COSTIMULATION
Lenschow, D. J., Walunas, T. L., & Bluestone, J. A. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.233 · Cited by 2,717
Thornton, A. M., & Shevach, E. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.287 · Cited by 2,639
Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A., Paeper, B., Clark, L. B., Yasayko, S.-A., Wilkinson, J. E., Galas, D., Ziegler, S. F., & Ramsdell, F. (2001) · Nature Genetics · doi:10.1038/83784 · Cited by 2,636
Miyara, M., Yoshioka, Y., Kitoh, A., Shima, T., Wing, K., Niwa, A., Parizot, C., Taflin, C., Heike, T., Valeyre, D., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.03.019 · Cited by 2,291
CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.
Krummel, M. F., & Allison, J. P. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.2.459 · Cited by 2,245 · cited 1×
“This likely reflects theirhigher level of CTLA-4 expression and the fact that they express CTLA-4 constitutively, unlike Tconv that require a 2 day window to upregulate this protein [100,101,132].”
BackgroundTakahashi, T., Tagami, T., Yamazaki, S., Uede, T., Shimizu, J., Sakaguchi, N., Mak, T. W., & Sakaguchi, S. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.303 · Cited by 2,233
CTLA-4 can function as a negative regulator of T cell activation
Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B., & Bluestone, J. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90071-x · Cited by 2,222
Read, S., Malmström, V., & Powrie, F. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.295 · Cited by 2,205
Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease
Ueda, H., Howson, J. M. M., Esposito, L., Heward, J., Snook, Chamberlain, G., Rainbow, D. B., Hunter, K. M. D., Smith, A. N., Di Genova, G., et al. (2003) · Nature · doi:10.1038/nature01621 · Cited by 2,175
Feuerer, M., Herrero, L., Cipolletta, D., Naaz, A., Wong, J., Nayer, A., Lee, J., Goldfine, A. B., Benoist, C., Shoelson, S., et al. (2009) · Nature Medicine · doi:10.1038/nm.2002 · Cited by 2,145
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4
Qureshi, O. S., Zheng, Y., Nakamura, K., Attridge, K., Manzotti, C., Schmidt, E. M., Baker, J., Jeffery, L. E., Kaur, S., Briggs, Z., et al. (2011) · Science · doi:10.1126/science.1202947 · Cited by 1,860 · cited 2×
“A key piece in this puzzle has been provided by the demonstration that CTLA-4 can physically remove its ligands from antigen presenting cells by a process of trans-endocytosis, affording a mechanism for Treg to regulate CD28 stimulation of other T cells [99].”
BackgroundRegulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice
Kim, J. M., Rasmussen, J. P., & Rudensky, A. Y. (2007) · Nature Immunology · doi:10.1038/ni1428 · Cited by 1,820
Regulatory T cells mediate maternal tolerance to the fetus
Aluvihare, V. R., Kallikourdis, M., & Betz, A. G. (2004) · Nature Immunology · doi:10.1038/ni1037 · Cited by 1,657
Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1
Dang, E. V., Barbi, J., Yang, H.-Y., Jinasena, D., Yu, H., Zheng, Y., Bordman, Z., Fu, J., Kim, Y., Yen, H.-R., et al. (2011) · Cell · doi:10.1016/j.cell.2011.07.033 · Cited by 1,595
Sakaguchi, S., Sakaguchi, N., Shimizu, J., Yamazaki, S., Sakihama, T., Itoh, M., Kuniyasu, Y., Nomura, T., Toda, M., & Takahashi, T. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1820102.x · Cited by 1,505
Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation.
Asano, M., Toda, M., Sakaguchi, N., & Sakaguchi, S. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.387 · Cited by 1,330
Foxp3+ follicular regulatory T cells control the germinal center response
Linterman, M. A., Pierson, W., Lee, S. K., Kallies, A., Kawamoto, S., Rayner, T. F., Srivastava, M., Divekar, D. P., Beaton, L., Hogan, J. J., et al. (2011) · Nature Medicine · doi:10.1038/nm.2425 · Cited by 1,292
Koch, M. A., Tucker-Heard, G., Perdue, N. R., Killebrew, J. R., Urdahl, K. B., & Campbell, D. J. (2009) · Nature Immunology · doi:10.1038/ni.1731 · Cited by 1,258
Jonuleit, H., Schmitt, E., Stassen, M., Tuettenberg, A., Knop, J., & Enk, A. H. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.11.1285 · Cited by 1,255
FOXP3 Controls Regulatory T Cell Function through Cooperation with NFAT
Wu, Y., Borde, M., Heissmeyer, V., Feuerer, M., Lapan, A. D., Stroud, J. C., Bates, D. L., Guo, L., Han, A., Ziegler, S. F., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.042 · Cited by 1,189
PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells
Cipolletta, D., Feuerer, M., Li, A., Kamei, N., Lee, J., Shoelson, S. E., Benoist, C., & Mathis, D. (2012) · Nature · doi:10.1038/nature11132 · Cited by 1,143
Foxp3-dependent programme of regulatory T-cell differentiation
Gavin, M. A., Rasmussen, J. P., Fontenot, J. D., Vasta, V., Manganiello, V. C., Beavo, J. A., & Rudensky, A. Y. (2007) · Nature · doi:10.1038/nature05543 · Cited by 1,135
Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions
Chung, Y., Tanaka, S., Chu, F., Nurieva, R. I., Martinez, G. J., Rawal, S., Wang, Y.-H., Lim, H., Reynolds, J. M., Zhou, X.-H., et al. (2011) · Nature Medicine · doi:10.1038/nm.2426 · Cited by 1,120
The Foxp3+ regulatory T cell: a jack of all trades, master of regulation
Tang, Q., & Bluestone, J. A. (2008) · Nature Immunology · doi:10.1038/ni1572 · Cited by 1,031
CD4 + Regulatory T Cells Control T H 17 Responses in a Stat3-Dependent Manner
Chaudhry, A., Rudra, D., Treuting, P., Samstein, R. M., Liang, Y., Kas, A., & Rudensky, A. Y. (2009) · Science · doi:10.1126/science.1172702 · Cited by 1,000
Peggs, K. S., Quezada, S. A., Chambers, C. A., Korman, A. J., & Allison, J. P. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082492 · Cited by 967
Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control TH2 responses
Zheng, Y., Chaudhry, A., Kas, A., deRoos, P., Kim, J. M., Chu, T.-T., Corcoran, L., Treuting, P., Klein, U., & Rudensky, A. Y. (2009) · Nature · doi:10.1038/nature07674 · Cited by 958
Krummel, M. F., & Allison, J. P. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2533 · Cited by 932
CD28 and CTLA-4 coreceptor expression and signal transduction
Rudd, C. E., Taylor, A., & Schneider, H. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00770.x · Cited by 898
Suri-Payer, E., Amar, A. Z., Thornton, A. M., & Shevach, E. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1212 · Cited by 860
Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells
Zheng, Y., Josefowicz, S. Z., Kas, A., Chu, T.-T., Gavin, M. A., & Rudensky, A. Y. (2007) · Nature · doi:10.1038/nature05563 · Cited by 835
Nistico, L. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.7.1075 · Cited by 809
CTLA-4 ligation blocks CD28-dependent T cell activation.
Walunas, T. L., Bakker, C. Y., & Bluestone, J. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2541 · Cited by 801
The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses
Walker, L. S. K., & Sansom, D. M. (2011) · Nature Reviews Immunology · doi:10.1038/nri3108 · Cited by 786
Self-citationSomerset, D. A., Zheng, Y., Kilby, M. D., Sansom, D. M., & Drayson, M. T. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01869.x · Cited by 777
Ohkura, N., Hamaguchi, M., Morikawa, H., Sugimura, K., Tanaka, A., Ito, Y., Osaki, M., Tanaka, Y., Yamashita, R., Nakano, N., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.09.010 · Cited by 754
Foxp3 occupancy and regulation of key target genes during T-cell stimulation
Marson, A., Kretschmer, K., Frampton, G. M., Jacobsen, E. S., Polansky, J. K., MacIsaac, K. D., Levine, S. S., Fraenkel, E., von Boehmer, H., & Young, R. A. (2007) · Nature · doi:10.1038/nature05478 · Cited by 724 · cited 1×
“Analysis of Foxp3-bound genes has uncovered numerous targets [67,68], however none fulfilled the “holy grail” criterion of providing a convincing molecular explanation for Treg function.”
BackgroundOnishi, Y., Fehervari, Z., Yamaguchi, T., & Sakaguchi, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711106105 · Cited by 716
Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1
Ono, M., Yaguchi, H., Ohkura, N., Kitabayashi, I., Nagamura, Y., Nomura, T., Miyachi, Y., Tsukada, T., & Sakaguchi, S. (2007) · Nature · doi:10.1038/nature05673 · Cited by 690
The Interaction Properties of Costimulatory Molecules Revisited
Collins, A. V., Brodie, D. W., Gilbert, R. J. C., Iaboni, A., Manso-Sancho, R., Walse, B., Stuart, D. I., van der Merwe, P. A., & Davis, S. J. (2002) · Immunity · doi:10.1016/s1074-7613(02)00362-x · Cited by 684
The Emerging Role of CTLA-4 as an Immune Attenuator
Thompson, C. B., & Allison, J. P. (1997) · Immunity · doi:10.1016/s1074-7613(00)80366-0 · Cited by 634
Extrathymic Generation of Regulatory T Cells in Placental Mammals Mitigates Maternal-Fetal Conflict
Samstein, R. M., Josefowicz, S. Z., Arvey, A., Treuting, P. M., & Rudensky, A. Y. (2012) · Cell · doi:10.1016/j.cell.2012.05.031 · Cited by 623
Tai, X., Cowan, M., Feigenbaum, L., & Singer, A. (2005) · Nature Immunology · doi:10.1038/ni1160 · Cited by 613
Intracellular Trafficking of CTLA-4 and Focal Localization Towards Sites of TCR Engagement
Linsley, P. S., Bradshaw, J., Greene, J., Peach, R., Bennett, K. L., & Mittler, R. S. (1996) · Immunity · doi:10.1016/s1074-7613(00)80480-x · Cited by 609
Regulation of the Germinal Center Reaction by Foxp3+ Follicular Regulatory T Cells
Wollenberg, I., Agua-Doce, A., Hernández, A., Almeida, C., Oliveira, V. G., Faro, J., & Graca, L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101328 · Cited by 599
The enemy within: keeping self-reactive T cells at bay in the periphery
Walker, L. S. K., & Abbas, A. K. (2002) · Nature Reviews Immunology · doi:10.1038/nri701 · Cited by 596
Self-citationThe lifestyle of naturally occurring CD4+CD25+Foxp3+ regulatory T cells
Shevach, E. M., DiPaolo, R. A., Andersson, J., Zhao, D., Stephens, G. L., & Thornton, A. M. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00415.x · Cited by 590
Antigen-dependent Proliferation of CD4+ CD25+ Regulatory T Cells In Vivo
Walker, L. S. K., Chodos, A., Eggena, M., Dooms, H., & Abbas, A. K. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030315 · Cited by 588
Self-citationCoexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.
Linsley, P. S., Greene, J. L., Tan, P., Bradshaw, J., Ledbetter, J. A., Anasetti, C., & Damle, N. K. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.6.1595 · Cited by 581
Abnormal T-Cell Reactivity against Paternal Antigens in Spontaneous Abortion
Zenclussen, A. C., Gerlof, K., Zenclussen, M. L., Sollwedel, A., Bertoja, A. Z., Ritter, T., Kotsch, K., Leber, J., & Volk, H.-D. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62302-4 · Cited by 552
A MOLECULAR PERSPECTIVE OF CTLA-4 FUNCTION
Teft, W. A., Kirchhof, M. G., & Madrenas, J. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090535 · Cited by 518
Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells
Ouyang, W., Beckett, O., Ma, Q., Paik, J.-H., DePinho, R. A., & Li, M. O. (2010) · Nature Immunology · doi:10.1038/ni.1884 · Cited by 467
The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs
Allan, S. E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24685 · Cited by 444
Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo
Read, S., Greenwald, R., Izcue, A., Robinson, N., Mandelbrot, D., Francisco, L., Sharpe, A. H., & Powrie, F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4376 · Cited by 434 · cited 3×
“Accordingly regulation of colitis by wildtype Treg can be blocked by anti-CTLA-4 antibody, but CTLA-4-deficient Treg can instead utilize IL-10 to achieve regulation [33].”
BackgroundTranscription factor Foxp3 and its protein partners form a complex regulatory network
Rudra, D., deRoos, P., Chaudhry, A., Niec, R. E., Arvey, A., Samstein, R. M., Leslie, C., Shaffer, S. A., Goodlett, D. R., & Rudensky, A. Y. (2012) · Nature Immunology · doi:10.1038/ni.2402 · Cited by 430
CTLA-4 regulates induction of anergy in vivo
Greenwald, R. J., Boussiotis, V. A., Lorsbach, R. B., Abbas, A. K., & Sharpe, A. H. (2001) · Immunity · doi:10.1016/s1074-7613(01)00097-8 · Cited by 428 · cited 1×
“Extensive evidence supports the function of CTLA-4 in the Tconv compartment [104e111], including the demonstration that CTLA-4 regulates the Tconv response to soluble antigen [104] and to tissue-derived neo-self antigen [105] as well as modulating the capacity of Tconv to infiltrate antigenbearing tissues and cause de…”
BackgroundRecombinant Human IL-10 Prevents the Onset of Diabetes in the Nonobese Diabetic Mouse
Pennline, K. J., Roque-Gaffney, E., & Monahan, M. (1994) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1994.1068 · Cited by 424
Developmental regulation of Foxp3 expression during ontogeny
Fontenot, J. D., Dooley, J. L., Farr, A. G., & Rudensky, A. Y. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050784 · Cited by 417
Powrie, F., & Mason, D. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.6.1701 · Cited by 413
Chambers, C. A., Sullivan, T. J., & Allison, J. P. (1997) · Immunity · doi:10.1016/s1074-7613(00)80406-9 · Cited by 411
X-linked lymphoreticular disease in the scurfy (sf) mutant mouse.
Godfrey, V., Wilkinson, J. E., & Russell, L. B. (1991) · PubMed · Cited by 405
Bour‐Jordan, H., Esensten, J. H., Martinez‐Llordella, M., Penaranda, C., Stumpf, M., & Bluestone, J. A. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01011.x · Cited by 391
Phenotype, Localization, and Mechanism of Suppression of CD4+CD25+ Human Thymocytes
Annunziato, F., Cosmi, L., Liotta, F., Lazzeri, E., Manetti, R., Vanini, V., Romagnani, P., Maggi, E., & Romagnani, S. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020110 · Cited by 379
Distinct roles of CTLA‐4 and TGF‐β in CD4+CD25+ regulatory T cell function
Tang, Q., Boden, E. K., Henriksen, K. J., Bour‐Jordan, H., Bi, M., & Bluestone, J. A. (2004) · European Journal of Immunology · doi:10.1002/eji.200425143 · Cited by 377
CTLA-4: a negative regulator of autoimmune disease.
Karandikar, N. J., Vanderlugt, C. L., Walunas, T. L., Miller, S. D., & Bluestone, J. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.783 · Cited by 376
CD28, CTLA‐4 and their ligands: who does what and to whom?
Sansom, D. M. (2000) · Immunology · doi:10.1046/j.1365-2567.2000.00121.x · Cited by 362
Oderup, C., Cederbom, L., Makowska, A., Cilio, C. M., & Ivars, F. (2006) · Immunology · doi:10.1111/j.1365-2567.2006.02362.x · Cited by 338
Shima, T., Sasaki, Y., Itoh, M., Nakashima, A., Ishii, N., Sugamura, K., & Saito, S. (2010) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2010.02.006 · Cited by 317
Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis
Sekiya, T., Kashiwagi, I., Yoshida, R., Fukaya, T., Morita, R., Kimura, A., Ichinose, H., Metzger, D., Chambon, P., & Yoshimura, A. (2013) · Nature Immunology · doi:10.1038/ni.2520 · Cited by 314
Activation requirements for the induction of CD4+CD25+ T cell suppressor function
Thornton, A. M., Piccirillo, C. A., & Shevach, E. M. (2004) · European Journal of Immunology · doi:10.1002/eji.200324455 · Cited by 296
A multiply redundant genetic switch 'locks in' the transcriptional signature of regulatory T cells
Fu, W., Ergun, A., Lu, T., Hill, J. A., Haxhinasto, S., Fassett, M. S., Gazit, R., Adoro, S., Glimcher, L., Chan, S., et al. (2012) · Nature Immunology · doi:10.1038/ni.2420 · Cited by 296
Wogensen, L., Lee, M. S., & Sarvetnick, N. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1379 · Cited by 294
The role of CD28 and cytotoxic T‐lymphocyte antigen‐4 (CTLA‐4) in regulatory T‐cell biology
Sansom, D. M., & Walker, L. S. K. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00419.x · Cited by 293
Self-citationCytotoxic T Lymphocyte–associated Antigen 4 (CTLA-4) Regulates the Unfolding of Autoimmune Diabetes
Lühder, F., Höglund, P., Allison, J. P., Benoist, C., & Mathis, D. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.3.427 · Cited by 290
CTLA4 gene polymorphism and autoimmunity
Gough, S. C. L., Walker, L. S. K., & Sansom, D. M. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00249.x · Cited by 288
Self-citationCD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance
Friedline, R. H., Brown, D. S., Nguyen, H., Kornfeld, H., Lee, J., Zhang, Y., Appleby, M., Der, S. D., Kang, J., & Chambers, C. A. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081811 · Cited by 266
Jain, N., Nguyen, H., Chambers, C., & Kang, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910341107 · Cited by 256
Basis of CTLA-4 function in regulatory and conventional CD4+ T cells
Tai, X., Van Laethem, F., Pobezinsky, L., Guinter, T., Sharrow, S. O., Adams, A., Granger, L., Kruhlak, M., Lindsten, T., Thompson, C. B., et al. (2012) · Blood · doi:10.1182/blood-2011-11-388918 · Cited by 251
Role of regulatory T cells and FOXP3 in human diseases
Bacchetta, R., Gambineri, E., & Roncarolo, M.-G. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.06.023 · Cited by 249
Cutting Edge: A Soluble Form of CTLA-4 in Patients with Autoimmune Thyroid Disease
Oaks, M. K., & Hallett, K. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.5015 · Cited by 239
Cutting Edge: Lymphoproliferative Disease in the Absence of CTLA-4 Is Not T Cell Autonomous
Bachmann, M. F., Köhler, G., Ecabert, B., Mak, T. W., & Kopf, M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1128 · Cited by 235
Vijayakrishnan, L., Slavik, J. M., Illés, Z., Greenwald, R. J., Rainbow, D., Greve, B., Peterson, L. B., Hafler, D. A., Freeman, G. J., Sharpe, A. H., et al. (2004) · Immunity · doi:10.1016/s1074-7613(04)00110-4 · Cited by 218
CD38+ CD45RBlow CD4+ T cells: a population of T cells with immune regulatory activitiesin vitro
Read, S., Mauze, S., Asseman, C., Bean, A., Coffman, R., & Powrie, F. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199811)28:11<3435::aid-immu3435>3.0.co;2-p · Cited by 194
Antigen-specific peripheral shaping of the natural regulatory T cell population
Lathrop, S. K., Santacruz, N. A., Pham, D., Luo, J., & Hsieh, C.-S. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081359 · Cited by 188
Tivol, E. A., Boyd, S. D., McKeon, S., Borriello, F., Nickerson, P., Strom, T. B., & Sharpe, A. H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.11.5091 · Cited by 185
Cell-autonomous and -non-autonomous roles of CTLA-4 in immune regulation
Wing, K., Yamaguchi, T., & Sakaguchi, S. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.06.002 · Cited by 183
Sojka, D. K., Bruniquel, D., Schwartz, R. H., & Singh, N. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.6136 · Cited by 178
Schmidt, E. M., Wang, C. J., Ryan, G. A., Clough, L. E., Qureshi, O., Goodall, M. D., Abbas, A. K., Sharpe, A. H., Sansom, D. M., & Walker, L. S. K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.274 · Cited by 176
Self-citationIse, W., Kohyama, M., Nutsch, K. M., Lee, H. M., Suri, A., Unanue, E. R., Murphy, T. L., & Murphy, K. M. (2010) · Nature Immunology · doi:10.1038/ni.1835 · Cited by 171
The Amount of Scurfin Protein Determines Peripheral T Cell Number and Responsiveness
Khattri, R., Kasprowicz, D. J., Cox, T., Mortrud, M. T., Appleby, M. W., Brunkow, M. E., Ziegler, S. F., & Ramsdell, F. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.11.6312 · Cited by 169
Mandelbrot, D. A., McAdam, A. J., & Sharpe, A. H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.435 · Cited by 162
Manzotti, C. N., Tipping, H., Perry, L., Mead, K. I., Blair, P. J., Zheng, Y., & Sansom, D. M. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(2002010)32:10<2888::aid-immu2888>3.0.co;2-f · Cited by 149
CTLA‐4 is required by CD4 + CD25 + Treg to control CD4 + T‐cell lymphopenia‐induced proliferation
Sojka, D. K., Hughson, A. L., & Fowell, D. J. (2009) · European Journal of Immunology · doi:10.1002/eji.200838603 · Cited by 122
CTLA‐4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in mice
Kolar, P., Knieke, K., Hegel, J. K., Quandt, D., Burmester, G. R., Hoff, H., & Brunner-Weinzierl, M. C. (2008) · Arthritis & Rheumatism · doi:10.1002/art.24181 · Cited by 114
Pinpointing when T cell costimulatory receptor CTLA-4 must be engaged to dampen diabetogenic T cells
Lühder, F., Chambers, C. A., Allison, J. P., Benoist, C. O., & Mathis, D. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200348397 · Cited by 112
Cutting Edge: CTLA-4 on Effector T Cells Inhibits In Trans
Corse, E., & Allison, J. P. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200695 · Cited by 111
Tai, X., Laethem, F. V., Sharpe, A. H., & Singer, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706509104 · Cited by 109
Gerold, K. D., Zheng, P., Rainbow, D. B., Zernecke, A., Wicker, L. S., & Kissler, S. (2011) · Diabetes · doi:10.2337/db11-0130 · Cited by 102
Zheng, Y., Manzotti, C. N., Burke, F., Dussably, L., Qureshi, O., Walker, L. S. K., & Sansom, D. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.3.1683 · Cited by 101
Self-citationKomatsu, N., & Hori, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702004104 · Cited by 95
Cutting Edge: Cell-Extrinsic Immune Regulation by CTLA-4 Expressed on Conventional T Cells
Wang, C. J., Kenefeck, R., Wardzinski, L., Attridge, K., Manzotti, C. N., Schmidt, E. M., Qureshi, O., Sansom, D. M., & Walker, L. S. K. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200972 · Cited by 92
Self-citationB7-dependent T-cell costimulation in mice lacking CD28 and CTLA4
Mandelbrot, D. A., Oosterwegel, M. A., Shimizu, K., Yamada, A., Freeman, G. J., Mitchell, R. N., Sayegh, M. H., & Sharpe, A. H. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11710 · Cited by 84
Araki, M., Chung, D., Liu, S. M., Rainbow, D. B., Chamberlain, G., Garner, V. E. S., Hunter, K. M. D., Vijayakrishnan, L., Peterson, L. B., Oukka, M., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802610 · Cited by 84
The Plasticity of Regulatory T Cell Function
Pillai, M. R., Collison, L. W., Wang, X., Finkelstein, D., Rehg, J. E., Boyd, K. L., Szymczak-Workman, A. L., Doggett, T. A., Griffith, T. S., Ferguson, T. A., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102173 · Cited by 83
Cooperative Roles of CTLA-4 and Regulatory T Cells in Tolerance to an Islet Cell Antigen
Eggena, M. P., Walker, L. S. K., Nagabhushanam, V., Barron, L., Chodos, A. H., & Abbas, A. K. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040124 · Cited by 73
Self-citationCD25+CD4+ regulatory T cells exert in vitro suppressive activity independent of CTLA-4
Kataoka, H., Takahashi, S., Takase, K., Yamasaki, S., Yokosuka, T., Koike, T., & Saito, T. (2005) · International Immunology · doi:10.1093/intimm/dxh221 · Cited by 73
CD4+CD25+ T cells as immunoregulatory T cells in vitro
Chai, J., Tsang, J. Y., Lechler, R. I., Simpson, E., Dyson, J., & Scott, D. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200208)32:8<2365::aid-immu2365>3.0.co;2-2 · Cited by 65
Lack of Intrinsic CTLA-4 Expression Has Minimal Effect on Regulation of Antiviral T-Cell Immunity
Homann, D., Dummer, W., Wolfe, T., Rodrigo, E., Theofilopoulos, A. N., Oldstone, M. B. A., & von Herrath, M. G. (2005) · Journal of Virology · doi:10.1128/jvi.80.1.270-280.2006 · Cited by 56
Metzler, B., Burkhart, C., & Wraith, D. C. (1999) · International Immunology · doi:10.1093/intimm/11.5.667 · Cited by 54
Tivol, E. A., & Gorski, J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.1852 · Cited by 53
Verhagen, J., Gabryšová, L., Minaee, S., Sabatos, C. A., Anderson, G., Sharpe, A. H., & Wraith, D. C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803186106 · Cited by 52
Walker, L. S. K., Wiggett, H. E., Gaspal, F., Raykundalia, C., Goodall, M. D., Toellner, K., & Lane, P. J. L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.91 · Cited by 51
Self-citationButty, V. L., Roy, M., Sabeti, P. C., Besse, W., Benoist, C. O., & Mathis, D. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610124104 · Cited by 47
Huang, C., Martin, S., Pfleger, C., Du, J., Buckner, J. H., Bluestone, J. A., Riley, J. L., & Ziegler, S. F. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203561 · Cited by 45
The B7-Independent Isoform of CTLA-4 Functions To Regulate Autoimmune Diabetes
Stumpf, M., Zhou, X., & Bluestone, J. A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201362 · Cited by 43
Walker, L. S. K., Ausubel, L. J., Chodos, A. H., Bekarian, N., & Abbas, A. K. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.11.6202 · Cited by 41
Self-citationHybrid Treg cells: steel frames and plastic exteriors
Barnes, M. J., & Powrie, F. M. (2009) · Nature Immunology · doi:10.1038/ni0609-563 · Cited by 40
Expression of CTLA‐4 and FOXP3 in cis protects from lethal lymphoproliferative disease
Chikuma, S., & Bluestone, J. A. (2007) · European Journal of Immunology · doi:10.1002/eji.200737159 · Cited by 33
Chella David: A lifetime contribution in translational immunology
Gershwin, M. E., & Shoenfeld, Y. (2011) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.05.011 · Cited by 27
Overexpression of the CTLA-4 Isoform Lacking Exons 2 and 3 Causes Autoimmunity
Liu, S. M., Sutherland, A. P. R., Zhang, Z., Rainbow, D. B., Quintana, F. J., Paterson, A. M., Sharpe, A. H., Oukka, M., Wicker, L. S., & Kuchroo, V. K. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102042 · Cited by 27
Gozalo-Sanmillan, S., McNally, J. M., Lin, M. Y., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.2.727 · Cited by 24
Immune tolerance: Are regulatory T cell subsets needed to explain suppression of autoimmunity?
Tian, L., Humblet‐Baron, S., & Liston, A. (2012) · BioEssays · doi:10.1002/bies.201100180 · Cited by 22
Pierre Youinou: When intuition and determination meet autoimmunity
Jamin, C., Renaudineau, Y., & Pers, J. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.05.004 · Cited by 19
Tsuchihashi (2000) · doi:10.1002/1521-4141(200006)30:6
Cited by
A guide to cancer immunotherapy: from T cell basic science to clinical practice
Waldman, A. D., Fritz, J. M., & Lenardo, M. J. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0306-5 · Cited by 4,154
Okazaki, T., Chikuma, S., Iwai, Y., Fagarasan, S., & Honjo, T. (2013) · Nature Immunology · doi:10.1038/ni.2762 · Cited by 916
Autosomal dominant immune dysregulation syndrome in humans with CTLA4 mutations
Schubert, D., Bode, C., Kenefeck, R., Hou, T. Z., Wing, J. B., Kennedy, A., Bulashevska, A., Petersen, B.-S., Schäffer, A. A., Grüning, B. A., et al. (2014) · Nature Medicine · doi:10.1038/nm.3746 · Cited by 832
Self-citationCancer immunotherapies targeting the PD-1 signaling pathway
Iwai, Y., Hamanishi, J., Chamoto, K., & Honjo, T. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0329-9 · Cited by 635
Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response
Wang, D.-R., Wu, X.-L., & Sun, Y.-L. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01136-2 · Cited by 501
Metadata
- Authors
- Walker, L. S. K.
- Venue
- Journal of Autoimmunity
- Publisher
- Elsevier BV
- Published
- 2013-09
- Volume
- 45
- Pages
- 49-57
- ISSN
- 0896-8411 (ISSN-L)
- OpenAlex
- W1977144608
- Cited by
- 411
- References
- 136
- FWCI
- 11.64
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.